CD274 and neoplasm: In the 89 (72%) patients who had sufficient tumor tissues to evaluate quantifiable PD-L1 expression, 38 (43%) patients had PD-L1 negative expression, and 51 (57%) had PD-L1 positive expression, including 9 patients with more than 50% (≥ 50%) PD-L1 expression (Table 1).